Chemours (CC) Misses Q3 EPS by 7c

Chemours (NYSE: CC) reported Q3 EPS of $0.63, $0.07 worse than the analyst estimate of $0.70. Revenue for the quarter came in at $1.5 billion versus the consensus estimate of $1.52 billion.

For earnings history and earnings-related data on Chemours (CC) click here.

You May Also Be Interested In

• Ennis (EBF) Reports In-Line Q1 EPS
• Micron Technology (MU) PT Raised to $1,550 at Needham
• AbbVie agrees to acquire Apogee Therapeutics for $10.9 billion